TCR2 THERAPEUTICS INC's ticker is TCRR and the CUSIP is 87808K106. A total of 66 filers reported holding TCR2 THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.00 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $987,504 | +35.2% | 658,336 | -10.0% | 0.04% | +43.3% |
Q4 2022 | $730,501 | -62.9% | 731,379 | -33.2% | 0.03% | -60.5% |
Q3 2022 | $1,970,000 | -37.9% | 1,094,645 | 0.0% | 0.08% | -37.2% |
Q2 2022 | $3,174,000 | +5.1% | 1,094,645 | 0.0% | 0.12% | +28.7% |
Q1 2022 | $3,021,000 | -51.8% | 1,094,645 | -18.7% | 0.09% | -34.3% |
Q4 2021 | $6,273,000 | -80.7% | 1,346,058 | -64.7% | 0.14% | -74.7% |
Q3 2021 | $32,480,000 | -38.8% | 3,816,709 | +18.0% | 0.57% | -28.0% |
Q2 2021 | $53,100,000 | -33.4% | 3,235,809 | -10.4% | 0.79% | -30.0% |
Q1 2021 | $79,726,000 | -9.0% | 3,610,788 | +27.5% | 1.12% | +5.8% |
Q4 2020 | $87,621,000 | +54.4% | 2,832,888 | +1.4% | 1.06% | +1.8% |
Q3 2020 | $56,760,000 | +109.3% | 2,793,288 | +58.2% | 1.04% | +108.0% |
Q2 2020 | $27,113,000 | +98.2% | 1,765,188 | -0.1% | 0.50% | +30.8% |
Q1 2020 | $13,679,000 | -46.8% | 1,767,288 | -1.8% | 0.38% | -37.7% |
Q4 2019 | $25,692,000 | -4.5% | 1,799,188 | +0.5% | 0.62% | -31.7% |
Q3 2019 | $26,908,000 | +4.5% | 1,790,288 | -0.5% | 0.90% | +23.5% |
Q2 2019 | $25,747,000 | -10.2% | 1,799,216 | -0.4% | 0.73% | -13.1% |
Q1 2019 | $28,686,000 | – | 1,807,256 | – | 0.84% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM ASSET MANAGEMENT LLC | 4,050,865 | $4,046,814 | 1.69% |
MPM BioImpact LLC | 3,370,982 | $3,367,611 | 0.87% |
TANG CAPITAL MANAGEMENT LLC | 2,738,947 | $2,735,660 | 0.40% |
Newtyn Management, LLC | 1,075,000 | $1,073,710 | 0.22% |
HARBOR CAPITAL ADVISORS, INC. | 68,230 | $68,148 | 0.07% |
Artal Group S.A. | 750,000 | $749 | 0.04% |
Oasis Management Co Ltd. | 200,000 | $199,760 | 0.04% |
Redmile Group, LLC | 731,379 | $730,501 | 0.03% |
X-Square Capital, LLC | 31,919 | $32 | 0.02% |
CORNERCAP INVESTMENT COUNSEL INC | 68,035 | $67,953 | 0.01% |